Tyrosine kinase inhibitors-associated interstitial lung disease used in non-small cell lung cancer: a pharmacovigilance analysis based on the FDA adverse event reporting system database.

Jing Zhang,Ting Qiu,Yiting Zhou,Shengjie Wu,Enguo Chen

Expert opinion on drug safety（2023）

引用 0|浏览0

暂无评分

摘要

TKIs were significantly associated with ILD. More attention should be paid to female, older, MET group with shorter TTO, as their prognosis might be worse.

查看译文

关键词

Interstitial lung disease,data mining,disproportionality analysis,pharmacovigilance analysis,tyrosine kinase inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要